Emprumapimod
Emprumapimod (PF-07265803) is a selective, orally bioavailable p38α MAPK inhibitor that suppresses LPS-induced IL-6 production. It serves as a valuable research tool for investigating mechanisms and potential treatments for LMNA-related dilated cardiomyopathy in both cellular and animal models.
Product Specifications
CAS Number
765914-60-1
Product Name Alternative
ARRY-371797, p38MAPK, p38 MAPK, PF-07265803
Field of Research
Signal Transduction
Purity
99.10% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.97 mM) ; DMSO:80 mg/mL (168.95 mM)
Smiles
C (C (C) C) N1C=2C (=CC (OC3=C (F) C=C (F) C=C3) =C (C (N[C@@H] (CCN (C) C) C (N) =O) =O) C2) C=N1
Molecular Formula
C24H29F2N5O3
Molecular Weight
473.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0774903 1.0 µg DNA
FERMT1 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details